Active Ingredient History
Bimekizumab, sold under the brand name Bimzelx, is a humanized anti-IL17A, anti-IL-17F, and anti-IL17AF monoclonal antibody that is used to treat plaque psoriasis. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Arthritis, Psoriatic (Phase 3)
Arthritis, Rheumatoid (Phase 2)
Axial Spondyloarthritis (Phase 3)
Healthy Volunteers (Phase 1)
Hidradenitis Suppurativa (Phase 3)
Psoriasis (Phase 3)
Spondylitis, Ankylosing (Phase 3)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue